Market Place
Sourcing Support
6 pharma companies sign MoUs with Telangana for Pharma City
23 Nov 2024 //
BUSINESS STD
Hetero Labs`s Generics Mycophenolate Mofetil Receives Approval in US
22 Oct 2024 //
FDA
Hetero Lab`s Generics Milnacipran HCl Receives Approval in US
03 Oct 2024 //
FDA
Hetero`s Generic Pemetrexed Disodium Receives Approval in the U.S.
14 Jun 2024 //
FDA
Hetero Labs Generic Ertugliflozin Receives Tentative Approval in US
17 Apr 2024 //
FDA
Hetero`s Generic Eszopiclone Receives Approval in the U.S.
04 Jan 2024 //
FDA
Enforcement Report - Week of May 17, 2023
17 May 2023 //
FDA
India-based Hetero`s Paxlovid generic gets WHO backing
28 Dec 2022 //
REUTERS
Hetero`s Generic Linezolid Receives Approval in the U.S.
31 Oct 2022 //
FDA
Hetero`s Generic Naproxen Sodium Receives Approval in the U.S.
28 Oct 2022 //
FDA
Hetero Lab III Generic Ezetimibe Receives Approval in the U.S.
26 Jul 2022 //
FDA
Hetero Labs Generic Acyclovir Receives Approval in US
01 Jul 2022 //
FDA
Hetero lab III`s Generic Naproxen Receives Apprival in the U.S
07 Jun 2022 //
FDA
Hetero Drugs`s Generic Oseltamivir Phosphate Receives Approval in the U.S.
28 Mar 2022 //
FDA
Hetero gets CDSCO nod to make & sell Sputnik Light vaccine in India
21 Mar 2022 //
ECONOMIC TIMES
Hetero Labs` Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study
19 Feb 2022 //
FORBES
NPPA panel fixes retail price of Diclofenac transdermal patch
07 Feb 2022 //
MEDICALDIALOGUES
New toxic drug impurities detected in some heart pills in US
14 Oct 2021 //
ECONOMICTIMES
IT department detects Rs 550 crore in hidden income after raids
09 Oct 2021 //
ECONOMIC TIMES
Hetero Labs`s Generic Emtricitabine; Tenofovir Receives Approval in the US
07 Oct 2021 //
FDA
India likely to allow export of Sputnik Light COVID shot this month - sources
24 Sep 2021 //
REUTERS
SEC seeks permission for Hetero to start manufacturing Russian Sputnik V vaccine
21 Sep 2021 //
PHARMABIZ
Hetero gets emergency use nod to make Roche’s COVID-19 drug
07 Sep 2021 //
EXPRESSPHARMA
Hetero Labs`s Generic Tolterodine Tartrate Receives Tentative Approval In US
02 Aug 2021 //
FDA
India`s Hetero seeks emergency use nod for Merck`s COVID-19 drug
09 Jul 2021 //
REUTERS
Hetero Labs Ltd Iii`s Generic Lopinavir; Ritonavir Receives Approval In US
04 Jun 2021 //
FDA
Hetero Biopharma gets nod for Sputnik phase-3 trials
01 Jun 2021 //
ECONOMIC TIMES
Hetero Labs Unit`s Generic Loratadine Approval In US
12 May 2021 //
FDA
Hetero recalls a batch of its remdesivir brand Covifor after side effects
04 May 2021 //
BUSINESS STANDARD
Hetero gets SEC approval for phase 3 trials of Sputnik V
30 Apr 2021 //
INDIATIMES
Hetero enters into voluntary licensing pact with MSD to manufacture
26 Apr 2021 //
PHARMABIZ
GSK sells off $155M Zantac plant India to Hetero Labs for fraction of its cost
01 Apr 2021 //
FIERCE PHARMA
Hetero Healthcare plans a slew of PPE products
26 Dec 2020 //
THEHINDUBUSINESSLINE
RDIF AND HETERO AGREE TO PRODUCE OVER 100 MILLION DOSES
30 Nov 2020 //
SPUTNIKVACCINE
Russia`s Sputnik V COVID-19 to be produced in India; RDIF and Hetero agree
26 Nov 2020 //
MONEYCONTROL
Hetero Labs Unit`s Generic nebivolol hydrochloride Approval In US
06 Nov 2020 //
FDA
Six Indian drug companies to set up a large pharma cluster in Mexico
12 Oct 2020 //
ECONOMICTIMES
After tablets, Hetero working on antiviral medicine Favipiravir injections
08 Oct 2020 //
ECONOMICTIMES
Hetero Labs Unit`s Generic Dolutegravir Receives Tentative Approval In US
29 Sep 2020 //
FDA
Hetero launches pack of generic Covid-19 drug favipiravir at Rs 2,640
25 Sep 2020 //
BUSINESS-STANDARD
Hetero Labs Ltd III`s Generic Dimethyl Fumarate Receives Approval In US
24 Sep 2020 //
FDA
Enforcement Report - Week of September 2, 2020
02 Sep 2020 //
FDA
Hetero Labs gets Gujarat FDCA nod to MFG remdesivir injection through loan
11 Aug 2020 //
PHARMABIZ
Maharashtra gets 90,0000 remdesivir injections as manufacturers ramp up
30 Jul 2020 //
PHARMABIZ
Hetero announces the launch of ‘Favivir’ (Favipiravir 200 mg) in India
29 Jul 2020 //
PRESS RELEASE
Hetero launches Favivir to treat mild to moderate Covid-19
28 Jul 2020 //
EXPRESSPHARMA
Hetero starts supply of 60,000 vials of generic Remdesvir treatment of Covid-19
15 Jul 2020 //
ECONOMICTIMES
Hetero starts supply of 60,000 vials of generic Remdesvir for treatment
14 Jul 2020 //
ECONOMICTIMES
India`s Sovereign Pharma dispatches first batch of remdesivir to Cipla
07 Jul 2020 //
REUTERS
Hetero facilitates COVID-19 patients to access their remdesivir version
06 Jul 2020 //
MONEYCONTROL
Pharma major Mylan gets go-ahead to remdesivir for `restricted emergency use`
02 Jul 2020 //
ECONOMICTIMES
India poised to ramp up remdesivir production as Mylan & Jubilant Life Sciences
02 Jul 2020 //
PHARMABIZ
Mylan gets approval to make and market remdesivir
02 Jul 2020 //
EXPRESSPHARMA
Gujarat FDCA issues test license to Hetero to manufacture lyophilized injection
30 Jun 2020 //
PHARMABIZ
Hetero, Cipla get DCGI nod to Mfg remdesivir to treat COVID-19 patients in India
23 Jun 2020 //
BUSINESSTODAY
Hetero gets DCGI nod to launch Remdesivir for Covid-19 treatment
22 Jun 2020 //
ECONOMICTIMES
